ECCMID 2018: Patrick Harris

3 May 2018

ECCMID - The Society's annual congress: 21 – 24 April 2018 Madrid, Spain

ESCMID's yearly congress attracts over 12'000 participants. ECCMID offers a wide range of sessions including: keynotes, symposia, poster sessions, educational workshops, meet-the-expert sessions and more.

Dr Patrick Harris discusses MERINO trial: piperacillin-tazobactam vs meropenem in BSI.


Since its founding in 1983, ESCMID has evolved to become Europe’s leading society in clinical microbiology and infectious diseases with members from all European countries and all continents. For more than 30 years, ESCMID has been an influential component in the professional lives of microbiologists and infectious disease specialists and now reaches more than 7,000 individual and 30,000 affiliated members around the world. ESCMID, based in Basel, Switzerland, welcomes new colleagues from all nations.